NEW YORK – One Drop/Mobile app users reported a substantial improvement in glycemic control in a retrospective study released last month.
Users reported a reduction in A1c by 1% after two to 12 months of using the One Drop/Mobile app.
“These results suggest a clinically significant improvement in glycemic control comparable to first line therapies for diabetes,” said Dr.Chanda Osborn, vice president of health and bioinformatics at One Drop.
One Drop analyzed data from app users who self-identified as having either Type 1 or Type 2 diabetes and had entered two hemoglobin A1c values at least 60 days, but no more than one year, apart.
The initial analysis showed a 0.7% point reduction in A1c among the app users. It was repeated on a larger sample eight months later and found a 1.0% reduction. The more people tracked blood glucose and food in the One Drop/Mobile app, the more their A1 improved.
“This is just the tip of the iceberg,” said Osborn. “There’s much more rigorous science coming down the pike.”